EUVIMEDEUVIMED entdecken
Crossref

Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges

Lakshmikanta Lakshmikanta, Vaishalli Vaishalli, Mayank David Raiborde, G Kranthi Kishore, P. S. Vikhe, Mushini Srikanthakumari

International Journal of Drug Delivery Technology · 17.06.2026 · 16 (54s)

DOI: 10.25258/ijddt.16.54s.75 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 17.06.2026. Verfasst von Lakshmikanta Lakshmikanta und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stimuli-responsive nanocarriers represent one of the most sophisticated directions in targeted drug delivery because they are designed not merely to transport therapeutic agents, but to release them in response to specific biological or externally applied signals. Unlike conventional nanomedicines, which mainly depend on altered pharmacokinetics, passive accumulation, or surface-mediated targeting, stimuli-responsive systems integrate material engineering with disease microenvironment biology. These carriers can respond to endogenous stimuli such as acidic pH, redox gradients, enzymes, hypoxia, reactive oxygen species, adenosine triphosphate, and abnormal metabolic conditions, or to exogenous triggers such as temperature, light, magnetic fields, ultrasound, and electric fields. Their central objective is to maximize drug concentration at the pathological site while minimizing premature systemic leakage and off-target toxicity. This review critically examines the design principles, material platforms, release mechanisms, clinical progress, and translational limitations of stimuli-responsive nanocarriers for targeted drug delivery. Particular attention is given to pH-sensitive, thermosensitive, redox-responsive, enzyme-responsive, ultrasound-triggered, magnetic, light-activated, and multi-stimuli systems. The review also evaluates clinically advanced nanomedicines, including liposomal, albumin-bound, polymeric, and lipid-based formulations, while distinguishing between clinically approved nanomedicines and truly stimuli-responsive platforms still largely under investigation. Although several nanomedicines such as Doxil, Abraxane, Onivyde, Vyxeos, and Onpattro have demonstrated the clinical feasibility of nanoscale drug delivery, the clinical translation of stimuli-responsive systems remains limited by biological heterogeneity, weak predictability of the enhanced permeability and retention effect, complex manufacturing, incomplete safety profiling, regulatory uncertainty, and insufficient patient stratification. The future of this field will depend on simplified but programmable carrier design, clinically measurable biomarkers of responsiveness, scalable manufacturing, real-time imaging-guided delivery, and rational trial designs that select patients based on tumor biology rather than assuming uniform nanocarrier behavior. Stimuli-responsive nanocarriers therefore hold substantial promise, but their successful clinical translation requires a shift from highly complex laboratory prototypes toward reproducible, mechanism-driven, and clinically validated delivery technologies

Zitieren

APA

Lakshmikanta, L., Vaishalli, V., Raiborde, M. D., Kishore, G. K., Vikhe, P. S., & Srikanthakumari, M. (2026). Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges. International Journal of Drug Delivery Technology, 16(54s). https://doi.org/10.25258/ijddt.16.54s.75

Vancouver

Lakshmikanta L, Vaishalli V, Raiborde MD, Kishore GK, Vikhe PS, Srikanthakumari M. Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges. International Journal of Drug Delivery Technology. 2026;16(54s). doi:10.25258/ijddt.16.54s.75

BibTeX
@article{Lakshmikanta2026,
  author = {Lakshmikanta, Lakshmikanta and Vaishalli, Vaishalli and Raiborde, Mayank David and Kishore, G Kranthi and Vikhe, P. S. and Srikanthakumari, Mushini},
  title = {Stimuli-Responsive Nanocarriers for Targeted Drug Delivery: Design Strategies, Clinical Progress, and Translational Challenges},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {54s},
  doi = {10.25258/ijddt.16.54s.75}
}
Kostenlos starten →